(ETNB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed Arce from H.C.

BofA raised the firm’s price target on Akero Therapeutics (AKRO) to $35 from $30 and keeps a Neutral rating on the shares after updating the firm’s model for the “quiet” third quarter. Material ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

Thousands of people are dying needlessly from cancer in the UK because it is lagging behind other countries in earlier detection rates, according to Cancer Research UK. The finding is laid out in ...

Amid fears of an "extremely high level of violent protests," the Brampton Triveni Mandir and Community Centre has cancelled a Life Certificate Event.

The US should take over the UK's military bases in Cyprus cementing the US-Cypriot ties and getting rid of the colonial legacy of the island, Michael Rubin a former ...

November 12, 2024 • In a first-best world, we'd all save enough money and there'd be no scammers. In a second-best world, we'd all know how to protect ourselves.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...